Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The link between major histocompatibility complex antibodies and cell proliferation.

Valenzuela NM, Reed EF.

Transplant Rev (Orlando). 2011 Oct;25(4):154-66. doi: 10.1016/j.trre.2011.04.001. Epub 2011 Jul 30. Review.

2.

Antibody and complement in transplant vasculopathy.

Wehner J, Morrell CN, Reynolds T, Rodriguez ER, Baldwin WM 3rd.

Circ Res. 2007 Feb 2;100(2):191-203. Review.

3.
4.

Role of CD8+ lymphocytes in chronic rejection of transplanted hearts.

Fischbein MP, Yun J, Laks H, Irie Y, Fishbein MC, Bonavida B, Ardehali A.

J Thorac Cardiovasc Surg. 2002 Apr;123(4):803-9.

PMID:
11986610
5.

Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner.

Li F, Zhang X, Jin YP, Mulder A, Reed EF.

Hum Immunol. 2011 Dec;72(12):1150-9. doi: 10.1016/j.humimm.2011.09.004. Epub 2011 Oct 1.

6.

[Humoral effectors and cellular targets of chronic arterial wall allorejection].

Michel JB, Plissonnier D, Gomes D.

Bull Acad Natl Med. 2001;185(3):605-12; discussion 612-3. Review. French.

PMID:
11501267
7.
8.

Endothelial cells in allograft rejection.

Al-Lamki RS, Bradley JR, Pober JS.

Transplantation. 2008 Nov 27;86(10):1340-8. doi: 10.1097/TP.0b013e3181891d8b. Review.

9.

Donor-specific antibodies in allograft rejection: clinical and experimental data.

Rifle G, Mousson C, Martin L, Guignier F, Hajji K.

Transplantation. 2005 Feb 15;79(3 Suppl):S14-8. Review.

PMID:
15699738
10.

Mechanisms of human smooth muscle cell proliferation and transplant vasculopathy induced by HLA class I antibodies: in vitro and in vivo studies.

Trayssac M, Nègre-Salvayre A, Thomsen M.

Hum Immunol. 2012 Dec;73(12):1253-60. doi: 10.1016/j.humimm.2012.06.012. Epub 2012 Jul 10. Review.

PMID:
22789624
11.

Immunologic mechanisms of transplant rejection.

Mannon RB, Coffman TM.

Curr Opin Nephrol Hypertens. 1992 Dec;1(2):230-5. Review.

PMID:
1345622
14.
15.

Sequential immunological targeting of chronic experimental arterial allograft.

Plissonnier D, Nochy D, Poncet P, Mandet C, Hinglais N, Bariety J, Michel JB.

Transplantation. 1995 Sep 15;60(5):414-24.

PMID:
7676487
16.

Endothelial activation and chronic allograft rejection.

Orosz CG.

Clin Transplant. 1994 Jun;8(3 Pt 2):299-303.

PMID:
7520304
17.

Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival.

Wolf D, Schreiber TH, Tryphonopoulos P, Li S, Tzakis AG, Ruiz P, Podack ER.

Transplantation. 2012 Sep 27;94(6):569-74.

PMID:
22902792
18.

Direct and indirect effects of alloantibodies link neointimal and medial remodeling in graft arteriosclerosis.

Thaunat O, Louedec L, Dai J, Bellier F, Groyer E, Delignat S, Gaston AT, Caligiuri G, Joly E, Plissonnier D, Michel JB, Nicoletti A.

Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2359-65. Epub 2006 Aug 17.

19.

Anti-major histocompatibility complex class I-related chain A antibodies in organ transplantation.

Morales-Buenrostro LE, Alberú J.

Transplant Rev (Orlando). 2008 Jan;22(1):27-38. doi: 10.1016/j.trre.2007.09.006. Review.

PMID:
18631856
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk